782 related articles for article (PubMed ID: 33253437)
1. Correlation between pharmacokinetics and pharmacogenetics of Selective Serotonin Reuptake Inhibitors and Selective Serotonin and Noradrenaline Reuptake Inhibitors and maternal and neonatal outcomes: Results from a naturalistic study in patients with affective disorders.
Colombo A; Giordano F; Giorgetti F; Di Bernardo I; Bosi MF; Varinelli A; Cafaro R; Pileri P; Cetin I; Clementi E; Viganò CA; Dell'Osso B
Hum Psychopharmacol; 2021 May; 36(3):e2772. PubMed ID: 33253437
[TBL] [Abstract][Full Text] [Related]
2. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
[TBL] [Abstract][Full Text] [Related]
3. Serotonin reuptake inhibitors and breastfeeding: a systematic review.
Orsolini L; Bellantuono C
Hum Psychopharmacol; 2015 Jan; 30(1):4-20. PubMed ID: 25572308
[TBL] [Abstract][Full Text] [Related]
4. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
5. Postpartum Bleeding in Pregnant Women Receiving SSRIs/SNRIs: New Insights From a Descriptive Observational Study and an Analysis of Data from the FAERS Database.
Perrotta C; Giordano F; Colombo A; Carnovale C; Castiglioni M; Di Bernardo I; Giorgetti F; Pileri P; Clementi E; Viganò C
Clin Ther; 2019 Sep; 41(9):1755-1766. PubMed ID: 31371035
[TBL] [Abstract][Full Text] [Related]
6. Escitalopram in the treatment of major depressive disorder: a meta-analysis.
Kennedy SH; Andersen HF; Thase ME
Curr Med Res Opin; 2009 Jan; 25(1):161-75. PubMed ID: 19210149
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the Effects of Selective Serotonin (and Noradrenaline) Reuptake Inhibitors on the Risk of Dementia in Patients with Depression.
Kostev K; Bohlken J; Jacob L
J Alzheimers Dis; 2019; 69(2):577-583. PubMed ID: 31104029
[TBL] [Abstract][Full Text] [Related]
8. [TREATMENT OF SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITORS (SSRIS AND SNRIS) DURING PREGNANCY AND LACTATION].
Rozner L; Aisenberg Romano G; Klieger C; Bloch M
Harefuah; 2023 Feb; 162(2):86-91. PubMed ID: 36916077
[TBL] [Abstract][Full Text] [Related]
9. The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials.
Azizi M; Khani S; Kamali M; Elyasi F
Iran J Med Sci; 2022 May; 47(3):173-193. PubMed ID: 35634530
[TBL] [Abstract][Full Text] [Related]
10. Risk of stress cardiomyopathy associated with selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors: a real-world pharmacovigilance analysis.
Tan B; Chen L; Yan S; Pan H; Zhang J; Wei H
Sci Rep; 2024 Jul; 14(1):15167. PubMed ID: 38956425
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
Kennedy SH; Andersen HF; Lam RW
J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
[TBL] [Abstract][Full Text] [Related]
12. Selective serotonin reuptake inhibitors in affective disorders--I. Basic pharmacology.
Goodnick PJ; Goldstein BJ
J Psychopharmacol; 1998; 12(3 Suppl B):S5-20. PubMed ID: 9808077
[TBL] [Abstract][Full Text] [Related]
13. Do Maternal Pharmacogenetics Impact the Neonatal Abstinence Syndrome Following In Utero Exposure to Antidepressant Medications?
Shea AK; Wang DY; Snelgrove JW; Dalfen A; Hewko S; Murphy KE
J Obstet Gynaecol Can; 2021 Jun; 43(6):726-732. PubMed ID: 33303407
[TBL] [Abstract][Full Text] [Related]
14. Spotlight on the pharmacoeconomics of escitalopram in depression.
Croom KF; Plosker GL
CNS Drugs; 2004; 18(7):469-73. PubMed ID: 15139801
[TBL] [Abstract][Full Text] [Related]
15. Selective serotonin reuptake inhibitor use in pregnant women; pharmacogenetics, drug-drug interactions and adverse effects.
Ornoy A; Koren G
Expert Opin Drug Metab Toxicol; 2018 Mar; 14(3):247-259. PubMed ID: 29345153
[TBL] [Abstract][Full Text] [Related]
16. Depression and antidepressant treatment in the development of hypertensive disorders of pregnancy: Results from a prospective cohort study.
Galbally M; Watson SJ; Spigset O
Aust N Z J Psychiatry; 2023 Apr; 57(4):520-527. PubMed ID: 35786007
[TBL] [Abstract][Full Text] [Related]
17. Escitalopram: a review of its use in the management of major depressive disorder in adults.
Garnock-Jones KP; McCormack PL
CNS Drugs; 2010 Sep; 24(9):769-96. PubMed ID: 20806989
[TBL] [Abstract][Full Text] [Related]
18. Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor Use as a Predictor of a Diagnosis of Restless Legs Syndrome.
Bailey AL; Makela EH; Asberg K
J Psychiatr Pract; 2016 Jul; 22(4):263-9. PubMed ID: 27427838
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review.
Handley AP; Williams M
J Am Assoc Nurse Pract; 2015 Jan; 27(1):54-61. PubMed ID: 24944075
[TBL] [Abstract][Full Text] [Related]
20. Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition.
Westin AA; Brekke M; Molden E; Skogvoll E; Spigset O
PLoS One; 2017; 12(7):e0181082. PubMed ID: 28708853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]